Studies of the Safety and Immunogenicity of a Sabin Inactivated Poliovirus Vaccine

NCT02985320 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

COMPLETED

Status

708

Enrollment

INDUSTRY

Sponsor class

Conditions

Poliomyelitis

Interventions

BIOLOGICAL: Single-dose regimen of high dosage investigational sIPV
BIOLOGICAL: Single-dose regimen of medium dosage investigational sIPV
BIOLOGICAL: Three-dose regimen of high dosage investigational sIPV
BIOLOGICAL: Three-dose regimen of medium dosage investigational sIPV
BIOLOGICAL: Three-dose regimen of low dosage investigational sIPV
BIOLOGICAL: Three-dose regimen of commercialized sIPV
BIOLOGICAL: Three-dose regimen of commercialized IPV

Sponsor

Sinovac Biotech Co., Ltd